Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ASCENDIS PHARMA A/S

(ASND)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Analyst Recommendations on ASCENDIS PHARMA A/S
01/13Wedbush Raises Price Target for Ascendis Pharma A/S to $189 From $186 on EU Approval fo..
MT
01/13Wedbush Cuts Ascendis Pharma's PT to $186 From $191 on Skytrofa Contraindication for PW..
MT
01/06Cowen Starts Ascendis Pharma at Market Perform With $136 Price Target
MT
2021Wells Fargo Starts Ascendis Pharma at Overweight With $176 Price Target
MT
2021SVB Leerink Adjusts Ascendis Pharma's Price Target to $190 from $182, Keeps Outperform ..
MT
2021Credit Suisse Lowers Ascendis Pharma's PT to $179 from $185, Updates Model with Q3 Actu..
MT
2021ASCENDIS PHARMA A/S : BofA Securities Downgrades Ascendis Pharma to Neutral From Buy, Lift..
MT
2021ASCENDIS PHARMA A/S : Wedbush Lifts Price Target for Ascendis Pharma A/S to $191 From $187..
MT
2021ASCENDIS PHARMA A/S : Morgan Stanley Adjusts Ascendis Pharma PT to $204 From $197, Maintai..
MT
2021ASCENDIS PHARMA A/S : JPMorgan Adjusts Ascendis Pharma PT to $175 From $172, Maintains Ove..
MT
2021ASCENDIS PHARMA A/S : Cantor Fitzgerald Adjusts Ascendis Pharma PT to $214 From $201, Main..
MT
2021ASCENDIS PHARMA A/S : Credit Suisse Raises Ascendis Pharma's PT to $185 from $178 After FD..
MT
2021ASCENDIS PHARMA A/S : SVB Leerink Adjusts Ascendis Pharma's Price Target to $182 from $178..
MT
2021ASCENDIS PHARMA A/S : Wedbush Lifts Ascendis Pharma's PT to $187 From $184 on Skytrofa's F..
MT
2021ASCENDIS PHARMA A/S : Wedbush Removes Outperform-Rated Ascendis Pharma From Best Ideas Lis..
MT
2021ASCENDIS PHARMA A/S : SVB Leerink Adjusts Ascendis Pharma A/S Price Target to $178 From $1..
MT
2021ASCENDIS PHARMA A/S : Wedbush Adjusts Price Target for Ascendis Pharma A/S to $184 From $1..
MT
2021ASCENDIS PHARMA A/S : Morgan Stanley Adjusts Ascendis Pharma's Price Target to $197 From $..
MT
2021ASCENDIS PHARMA A/S : SVB Leerink Adjusts Ascendis Pharma's Price Target to $181 From $191..
MT
2021ASCENDIS PHARMA A/S : Wedbush Adjusts Ascendis Pharma's PT to $189 From $219 on Potential ..
MT
2021ASCENDIS PHARMA A/S : Canaccord Genuity Adjusts Ascendis Pharma's Price Target to $196 Fro..
MT
2021ASCENDIS PHARMA A/S : Morgan Stanley Adjusts Price Target on Ascendis Pharma to $201 From ..
MT
2021ASCENDIS PHARMA A/S : Credit Suisse Raises Ascendis Pharma's PT to $178 from $176, Notes P..
MT
2021ASCENDIS PHARMA A/S : Wedbush Adjusts Ascendis Pharma's PT to $219 From $209 on TC-PTH/Hyp..
MT
2021ASCENDIS PHARMA A/S : Oppenheimer Downgrades Ascendis Pharma to Perform Rating From Outper..
MT
2021ASCENDIS PHARMA A/S : Wedbush Adds Outperform-Rated Ascendis Pharma to Best Ideas List Ahe..
MT
2021ASCENDIS PHARMA A/S : Canaccord Adjusts Ascendis Pharma A/S' Price Target to $190 from $17..
MT
2021ASCENDIS PHARMA A/S : Stifel Reinstates Ascendis Pharma at Buy With $190 Price Target
MT
2021ASCENDIS PHARMA A/S : Credit Suisse Raises Ascendis Pharma's Price Target to $176 From $17..
MT
2020ASCENDIS PHARMA A/S : Berenberg Starts Ascendis Pharma at Buy With $216 Price Target
MT
2020ASCENDIS PHARMA A/S : Wedbush Adjusts Price Target on Ascendis Pharma A/S to $209 From $20..
MT
2020ASCENDIS PHARMA A/S : Morgan Stanley Adjusts Ascendis Pharma's Price Target to $199 from $..
MT
2020ASCENDIS PHARMA A/S : JP Morgan Adjusts Price Target for Ascendis Pharma A/S to $166 From ..
MT
2020ASCENDIS PHARMA A/S : Wells Fargo Adjusts Ascendis Pharma's Price Target to $190 from $176..
MT
2020ASCENDIS PHARMA A/S : Credit Suisse Adjusts Ascendis Pharma's Price Target to $178 From $1..
MT
2020ASCENDIS PHARMA A/S : SVB Leerink Adjusts Ascendis Pharma's Price Target to $191 from $173..
MT
Upcoming event on ASCENDIS PHARMA A/S